Lars Röse

1.8k total citations · 2 hit papers
12 papers, 1.5k citations indexed

About

Lars Röse is a scholar working on Dermatology, Molecular Biology and Oncology. According to data from OpenAlex, Lars Röse has authored 12 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Dermatology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Lars Röse's work include Dermatology and Skin Diseases (5 papers), Contact Dermatitis and Allergies (2 papers) and Estrogen and related hormone effects (2 papers). Lars Röse is often cited by papers focused on Dermatology and Skin Diseases (5 papers), Contact Dermatitis and Allergies (2 papers) and Estrogen and related hormone effects (2 papers). Lars Röse collaborates with scholars based in Germany and United States. Lars Röse's co-authors include A Watzlik, Gerhard Opelz, Thomas M. Bauer, Peter Terness, Thomas M. Zollner, Oliver von Ahsen, Tobias M. Gorges, Ingeborg Tinhofer, Thomas Krahn and Michael Drosch and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Lars Röse

12 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells

2002 786 citations Peter Terness, Thomas M. Bauer et al. The Journal of Experimental Medicine profile →
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition

2012 452 citations Tobias M. Gorges, Ingeborg Tinhofer et al. BMC Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Röse Germany	11	522	482	443	282	254	12	1.5k
Theodore S. Johnson United States	16	475 0.9×	1.2k 2.5×	664 1.5×	333 1.2×	70 0.3×	27	2.0k
Rohit Gupta United States	11	1.7k 3.2×	2.0k 4.2×	202 0.5×	842 3.0×	293 1.2×	14	3.3k
Laura Mandik‐Nayak United States	26	448 0.9×	1.5k 3.1×	940 2.1×	651 2.3×	141 0.6×	45	2.7k
Alexey Boyко Russia	24	491 0.9×	689 1.4×	133 0.3×	544 1.9×	114 0.4×	76	2.7k
Courtney Smith United States	8	318 0.6×	573 1.2×	410 0.9×	329 1.2×	75 0.3×	13	1.1k
K. Brandstetter United States	10	748 1.4×	127 0.3×	157 0.4×	1.5k 5.2×	650 2.6×	25	2.5k
Sara Valpione Italy	26	1.2k 2.3×	781 1.6×	60 0.1×	478 1.7×	250 1.0×	47	2.4k
Seiji Nomura Japan	27	556 1.1×	294 0.6×	155 0.3×	624 2.2×	211 0.8×	98	2.2k
Ursula Grohmann Italy	13	160 0.3×	690 1.4×	425 1.0×	258 0.9×	38 0.1×	20	1.2k
Rasoul Baharlou Iran	15	210 0.4×	190 0.4×	78 0.2×	278 1.0×	112 0.4×	55	783

Countries citing papers authored by Lars Röse

Since Specialization

Citations

This map shows the geographic impact of Lars Röse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Röse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Röse more than expected).

Fields of papers citing papers by Lars Röse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Röse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Röse. The network helps show where Lars Röse may publish in the future.

Co-authorship network of co-authors of Lars Röse

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Röse. A scholar is included among the top collaborators of Lars Röse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Röse. Lars Röse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Hoff, Sabine, Sylvia Grünewald, Lars Röse, & Dieter Zopf. (2017). Immunomodulation by regorafenib alone and in combination with anti PD1 antibody on murine models of colorectal cancer. Annals of Oncology. 28. v423–v423. 40 indexed citations

Gorges, Tobias M., Ingeborg Tinhofer, Michael Drosch, et al.. (2012). Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer. 12(1). 178–178. 452 indexed citations breakdown →

Rudolph, Marion, Wolf‐Dietrich Döcke, A.R Müller, et al.. (2012). Induction of Overt Menstruation in Intact Mice. PLoS ONE. 7(3). e32922–e32922. 37 indexed citations

Wiehr, Stefan, Oliver von Ahsen, Lars Röse, et al.. (2012). Preclinical Evaluation of a Novel c-Met Inhibitor in a Gastric Cancer Xenograft Model Using Small Animal PET. Molecular Imaging and Biology. 15(2). 203–211. 10 indexed citations

Röse, Lars, et al.. (2011). Extended DNFB‐induced contact hypersensitivity models display characteristics of chronic inflammatory dermatoses. Experimental Dermatology. 21(1). 25–31. 28 indexed citations

Kerzerho, Jérôme, Natacha Szely, Hellmuth‐Alexander Meyer, et al.. (2011). Effects of Systemic versus Local Administration of Corticosteroids on Mucosal Tolerance. The Journal of Immunology. 188(1). 470–476. 17 indexed citations

Bonin, Arne von, Alexandra Rausch, Anne Mengel, et al.. (2010). Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases. Experimental Dermatology. 20(1). 41–47. 36 indexed citations

Schatz, Christoph A., et al.. (2010). Abstract 2704: Efficacy and candidate biomarker evaluation for the anti-MN immunoconjugate BAY 79-4620, MN-IC in MN (CAIX) positive preclinical xenograft models. Cancer Research. 70(8_Supplement). 2704–2704. 1 indexed citations

Schottelius, Arndt, Ulrich Zügel, Wolf‐Dietrich Döcke, et al.. (2009). The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in the p38/TNF-α Pathway of Systemic and Cutaneous Inflammation. Journal of Investigative Dermatology. 130(2). 481–491. 36 indexed citations

10.

Döcke, Wolf‐Dietrich, et al.. (2008). Chronic Mouse Model of TMA-Induced Contact Hypersensitivity. Journal of Investigative Dermatology. 129(4). 899–907. 50 indexed citations

11.

Döcke, Wolf‐Dietrich, et al.. (2007). Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate. Experimental Dermatology. 16(9). 753–761. 16 indexed citations

12.

Terness, Peter, et al.. (2002). Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells. The Journal of Experimental Medicine. 196(4). 447–457. 786 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact